Allogeneic Hematopoietic Stem Cell Transplant for People With Primary Immunodeficiency Diseases

Conditions:   Lymphoproliferative Disorders;   Autoimmune Lymphoproliferative;   Immune System Diseases;   Common Variable Immunodeficiency;   Primary T-cell Immunodeficiency Disorders Interventions:   Drug: Busulfan test dose;   Drug: Fludarabine;   Drug: Busulfan;   Drug: Alemtuzumab;   Radiation: Total body Irradiation;   Procedure: Allogeneic HSCT;   Drug: Tacrolimus (Tacro);   Drug: Mycophenolate mofetil (MMF);   Drug: Cyclophosphamide (Cytoxan);   Other: No i ntervention Sponsor:   National Cancer Institute (NCI) Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials